U.S. federal trademark · Serial No. 85851789 · Reg. No. 2609451
Pharmaceuticals for use in stimulating human blood cell production; Pharmaceuticals for the treatment of cancer. anemia, ischemia, myocardial infarction, congestive heart failure, renal failure; anoxia-induced cellular degeneration; hypoxia-induced cellular degeneration and stroke
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.